Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.
EXPLORE OUR SPECIALTIES BROWSE OUR TOPICS SUBSCRIBE TO RECEIVE UPDATES
Featured In Digestive Health
AGA Guideline Makes the Case for Biomarkers in Managing Crohn's Disease
Ashwin Ananthakrishnan, MD, discusses the AGA guideline's key recommendations for managing Crohn's disease and the evolving role of biomarkers in these treatments.
Featured In Cardiovascular
New Program Helps High School Students Explore Careers in Cardiology
A Massachusetts General Hospital cardiology fellow launched You Belong in Cardiology to build a pipeline for women and underrepresented minorities in cardiology.
Featured In Neuroscience
Imaging Technology Advances Multiple Sclerosis Research
Massachusetts General Hospital is developing and testing new imaging techniques to better understand multiple sclerosis (MS) pathology, physical symptoms and cognitive impairment associated with MS.
Featured In Rheumatology, Allergy and Immunology
Mass General Program One of the Few in the World to Focus on Vasculitis Patients
Sebastian Unizony, MD, and Zachary S. Wallace, MD, MSc, co-directors of the Vasculitis Program at Massachusetts General Hospital, discuss the program's multidisciplinary approach to care and pioneering research efforts.
Featured In Oncology
Program Co-Chair, Keith Flaherty, MD, Recaps Key Highlights From AACR 2024
Keith Flaherty, MD, director of clinical research at Mass General Cancer Center and program co-chair of this year's AACR Annual Meeting, shares key highlights and favorite talks from the conference.
The Latest Orthopaedic Advances
Pathways Case Record: Profound Weight Loss in a Patient With Polymyositis and Small Bowel Inflammation
A patient presented with severe malnutrition and an unintentional estimated weight loss of 160 pounds over three years. The Pathways Consult Service at Massachusetts General Hospital investigated the patient's concomitant skeletal and smooth muscle inflammation and gut dysmotility.
Vancomycin–Gentamicin Calcium Sulfate Beads May Predispose to Polymicrobial Infections After Adult Spinal Deformity Surgery
Massachusetts General Hospital researchers conclude from a feasibility study that it's too soon to recommend widespread use of combination antibiotics as infection prophylaxis for spine surgery because adults receiving vancomycin–gentamicin calcium sulfate beads exhibited a propensity to polymicrobial infections.
Contributing Physicians
Ebru Oral, PhD
Associate Director, Biomaterials, Harris Orthopaedics Lab, Associate Professor of Orthopedic Surgery, Harvard Medical School
Stuart H. Hershman, MD
Director, Adult Spinal Deformity & Spinal Reconstruction, Site Director, Orthopaedic Spine Surgery Fellowship, Massachusetts General Hospital, Assistant Professor of Orthopaedic Surgery, Harvard Medical School
Advances Specialties
Neuroscience
Essential Tremor Treatment Advancements Using MRI-guided Focused Ultrasound: Q&A With Jeffrey S. Schweitzer, MD, PhD
Jeffrey S. Schweitzer, MD, PhD, a neurosurgeon at Massachusetts Hospital, specializing in treating epilepsy, essential tremor, and tremor-dominant Parkinson's diseases. In this Q&A, Dr. Schweitzer discusses the physiological processes underlying essential tremor and the advancements.
OB/GYN
Comprehensive Lymphadenectomy Often Not Necessary in Surgical Management of Primary Endometrioid Ovarian Carcinoma
Varvara Mazina, MD, Marcela G. del Carmen, MD, MPH, and colleagues showed in a retrospective cohort of 63 women with primary endometrioid ovarian cancer that all pelvic and para-aortic lymph nodes removed were negative for carcinoma and comprehensive cancer staging had no effect on progression-free or overall survival.
Urology
Less Aggressive Protocol Suitable for Muscle-invasive Bladder Cancer in Noncystectomy Candidates
Douglas M. Dahl, MD, Jason A. Efstathiou, MD, DPhil, and colleagues determined that in patients with muscle-invasive bladder cancer who were not candidates for cystectomy or cisplatin, maximum tumor resection and chemoradiation were associated with high response rates and five-year overall survival rates of 25% to 38%.
May 4-8, 2024
Conference: American Psychiatric Association 2024 Annual Meeting
Considered the premier psychiatry event of the year, the American Psychiatric Association's 2024 Annual Meeting takes place May 4–8 in New York City. The Department of Psychiatry at Massachusetts General Hospital will present their latest research at this year's event.
May 16-19, 2024
Conference: Heart Rhythm 2024
Massachusetts General Hospital faculty will join the global electrophysiology community at Heart Rhythm 2024, an annual meeting and educational program hosted by the Heart Rhythm Society on May 16 - 19, 2024 in Boston, MA.
